收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 Barriers and motivators to national board certification as a certified anticoagulation care provider Rudd, Kelly M., Oertel... 761
2 Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study Deitelzweig, Steve, Luo... 766
3 Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS Brueckner, Lea, Beyer-Westendorf... 777
4 Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease Gauchel, Nadine, Rieder... 788
5 A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines Elberry, Mostafa H., Abdelgawad... 798
6 Characteristics and comparisons of acute stroke in "recovered" to "active COVID-19 and "pre-pandemic" in Qatar database Akhtar, Naveed, Abid... 824
7 Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study Bonnefoy, Pierre-Benoit, Prevot... 829
8 Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes Shavadia, Jay S., Alemayehu... 841
9 Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation Papanastasiou, Anastasios, Kartas... 851
10 Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients Whitaker, Caitlyn, McKinney... 861